Loading dashboard
Experiments tailored to you
See what actually works for you. Connect your health data and track your progress.
A daily protein floor from real food, where enough amino acids at each meal keeps muscle repair supplied and digestion slow enough to stay full longer.
For appropriate adults, the most defensible evidence-based reason to test High Protein Intake is body-composition partitioning, satiety or meal-structure support, and adherence learning—not guaranteed weight loss, lean-mass gain, or cardiometabolic improvement.
Best read as a bounded nutrition self-experiment: hit and verify a declared 1.5–2.0 g/kg/day protein floor, then interpret body composition, appetite, weight, labs, and tolerability through energy balance, training context, source quality, and safety boundaries.
The strongest direct anchors are mostly hypocaloric, overweight/obesity, or controlled contexts near 1.5–1.6 g/kg/day, while many other sources are adjacent variants, mechanisms, safety boundaries, or external guidelines.
This group combines clean direct 1.5–1.6 g/kg/day anchors with lower-dose, percent-protein, maintenance, and historical higher-protein boundary records. Use it for cautious body-composition and selected metabolic framing while keeping adjacent records visibly downgraded and preserving null or mixed endpoint findings.
11 sources · 11 trials
Early higher-protein women-only RCT supports body-composition and triglyceride context, not direct floor claims.
Higher-protein context trial improved selected metabolic signals but likely sat below the protein-floor dose.
Higher-protein energy restriction matched weight loss overall, with triglyceride and fat-mass subgroup signals.
Higher-protein diet improved weight loss in metabolic syndrome, but broad biomarker separation was limited.
Large percent-protein RCT did not confirm superior long-term weight loss from higher protein assignment.
Higher-protein maintenance diet reduced regain and dropout after low-calorie weight loss.
Direct 1.5 g/kg/day trial did not preserve fat-free mass or resting energy expenditure in postmenopausal women.
Direct 1.6 g/kg/day RCT shows body-fat and several cardiometabolic advantages versus 0.8 g/kg/day.
Longer 1.6 g/kg/day RCT supports body-composition and lipid benefits more than simple scale-weight superiority.
Prescribed 1.6 g/kg/day improved percent body-fat loss but did not clearly preserve total lean mass.
Controlled 1.6 g/kg/day dose improved fat-free-mass partitioning and muscle protein synthesis versus 0.8 g/kg/day.
Reviews and dose-response syntheses help bound the 1.5–2.0 g/kg/day target, but they mix training, aging, energy deficit, and non-whole-diet contexts.
13 sources · 13 reviews
Expert review summarizes satiety, thermogenesis, and fat-free-mass rationale for moderately elevated protein.
Macronutrient appetite review supports measurement caution for satiety and intake endpoints.
Mechanistic review links protein to satiety, energy expenditure, and fat-free mass but keeps comorbidity claims inconclusive.
Review frames protein mechanisms and flags bone, calcium, and blood-pressure considerations.
DioGenes-centered review suggests higher protein plus lower GI helped maintenance, but protein is not isolated.
Elite-athlete review recommends 1.6-2.4 g/kg/day during weight loss but is population-specific.
Review proposes 1.2-1.6 g/kg/day and 25-30 g/meal as candidate targets but flags long-term adherence limits.
Higher-protein preloads acutely increased fullness, but the source cautions against extrapolating to weight outcomes.
Higher protein modestly reduced weight regain in a maintenance-focused meta-analysis.
Acute protein improved appetite and hormone markers; longer-term effects were inconclusive.
Protein above the RDA favored lean mass under energy restriction or resistance training, but not in nonstressed adults.
Increased-protein interventions produced a modest average body-weight reduction versus controls.
Enhanced protein preserved muscle mass during weight loss, but not strength or physical function.
These sources help separate protein effects from calorie deficit, maintenance after weight loss, short-term appetite mechanisms, and low-carbohydrate or ketogenic confounding.
18 sources · 18 trials
Protein preloads raised CCK and reduced intake versus glucose in an acute male preload study.
Different protein preloads similarly reduced acute ad libitum intake versus glucose.
High-protein ketogenic feeding reduced hunger and intake versus high-protein medium-carbohydrate feeding.
High-protein diets reduced short-term energy intake, but did not prove low-protein overconsumption.
High beef-protein intake reduced short-term energy intake, but protein leverage was incomplete.
Higher-protein energy-restricted diets improved sleep-quality indexes in two trials.
Protein intake did not affect appetite during high-altitude energy deficit.
High-protein TDR altered appetite hormones but not subjective appetite sensations.
High protein did not preserve fat-free mass during severe high-altitude energy deficit.
Higher protein supported lean-mass and satiety signals during weight loss.
During overfeeding, protein changed lean mass and expenditure but not fat storage.
Relatively higher protein, more than low carbohydrate, aligned with weight-loss and maintenance results.
Extra protein above an already high refeed intake did not enhance FFM restoration.
High-protein total diet replacement increased expenditure and produced negative fat balance acutely.
Added protein reduced regain and increased satiety after weight loss.
A 30 g/day protein supplement limited regain after weight loss.
Normal protein supported weight loss; elevated protein helped preserve REE and fat-free mass.
Protein supplements did not improve maintenance despite appetite and expenditure signals.
Meal distribution, breakfast protein, protein pacing, workout timing, and per-meal dose evidence should be optional implementation context, not a requirement for the base daily floor.
35 sources · 25 trials · 8 physiology studies · 1 review
Protein-pacing plus intermittent fasting shifted microbiome/metabolomic profiles in a bundled trial.
High-protein breakfast reduced postprandial ghrelin in an acute crossover study.
Timed whey plus exercise reduced visceral fat and improved insulin-resistance signals.
Balanced protein plus resistance training restored MPS during energy restriction in older men.
Protein-enriched foods increased daily protein intake in older rehab patients.
Breakfast protein/fiber did not clearly change appetite or lunch intake in a small crossover.
Protein pacing plus multicomponent exercise improved performance in trained women.
Protein-pacing caloric restriction was linked with body-composition and maintenance benefits.
40 g whey exceeded 20 g for acute MPS after whole-body resistance exercise.
Breakfast protein supplementation was reported to benefit skeletal muscle mass in older adults.
IF plus protein pacing outperformed caloric restriction for weight and visceral fat in extracted summary.
Large post-exercise protein bolus produced a prolonged anabolic response in acute physiology.
Protein-rich dairy breakfast improved satiety/concentration but not clearly daily energy intake.
Pulse feeding did not improve protein retention in young women.
Pulse feeding improved lean-mass measures in malnourished elderly patients, with limited functional signal.
Post-exercise distribution changed turnover/synthesis signals without clear net-balance separation.
20 g and 40 g whey stimulated MPS, but 40 g increased oxidation/urea without clear added MPS.
Breakfast/lunch protein supplementation increased lean tissue mass in older adults.
Higher protein helped appetite signals, but higher meal frequency did not clearly add benefit.
Protein-pacing improved performance/body-composition signals whether delivered by foods or supplements.
Review-level distribution evidence is mixed and heterogeneous.
High-protein breakfast improved satiety but not body composition or cardiometabolic markers.
PROMISS secondary analysis did not find distribution metrics useful for strength or walking outcomes.
Pulse feeding improved nitrogen-balance physiology in a small elderly-women study.
Even distribution with a higher-protein breakfast improved hypertrophy signals in young men during resistance training.
Even distribution improved some whole-body balance signals but not muscle FSR.
Even distribution did not influence body-composition changes during weight loss in women.
At 2 g/kg/day, exact workout-adjacent timing did not show a between-group advantage in trained men.
A moderate repeated post-exercise protein pattern increased acute myofibrillar protein synthesis.
Even meal distribution improved 24-hour muscle protein synthesis in a small controlled-feeding crossover.
Protein quantity improved net balance, but meal pattern did not show a clear independent effect.
Even protein distribution did not improve lean mass, strength, function, or anabolic response over 8 weeks.
Even distribution did not alter body-composition responses during weight loss plus resistance training.
Even distribution did not improve MPS or amino-acid utilization versus skewed distribution.
At 1.5 g/kg/day in two meals, net balance improved but MPS was not significantly different.
This group covers food-first versus supplement-assisted delivery, animal versus plant source comparisons, saturated fat, fiber displacement, meal replacement, and practicality.
29 sources · 17 trials · 5 supporting sources · 4 reviews
Matched high-protein vegan and omnivorous diets supported similar muscle protein synthesis and hypertrophy in young adults.
Meat and nonmeat sources differed on LDL-related markers under controlled feeding.
Higher protein did not protect lean mass or resting metabolic rate during very-low-calorie dieting.
Lean red meat plus resistance training improved muscle outcomes in elderly women, but the cointervention limits attribution.
Lean red meat plus exercise did not improve primary muscle or cognitive outcomes in older adults.
Protein amount showed some signals, but animal versus vegetarian source did not clearly dominate.
Higher-protein OmniHeart pattern improved cardiometabolic markers but is not a g/kg protein-floor test.
Plant-based meat alternatives improved selected biomarkers versus animal meat in a short crossover trial.
Protein quality may affect muscle anabolism, but evidence is heterogeneous and often mechanistic.
Plant-for-animal protein substitution may modestly improve lipid markers, but it is not protein-floor efficacy evidence.
Higher beef supplementation did not clearly improve post-weight-loss maintenance outcomes.
OmniHeart diet-pattern paper clarifies source delivery but is not standalone efficacy evidence.
Protein amount may influence energy expenditure; protein type has no clear thermogenesis advantage.
Lean beef inclusion did not outperform red-meat restriction inside high-protein weight loss.
Soy and meat high-protein weight-loss diets looked similar over short crossover periods.
Soy foods appeared comparable to non-soy protein foods inside a high-protein program.
Lean beef was compatible with short-term lipid improvements inside a low-saturated-fat diet pattern.
High-protein partial meal replacement improved weight-loss markers, but fasting added no clear advantage and micronutrients require monitoring.
High animal- and plant-protein diets reduced liver/metabolic markers in type 2 diabetes, but this is clinical-context evidence.
Self-prepared carbohydrate-reduced high-protein dieting improved markers in type 2 diabetes, but it is clinical adjacent evidence.
Protein-increase advice in older adults changed more than protein alone.
Supplement-plus-training signals are positive but confounded by resistance training and calorie restriction.
Young active adults mostly met high protein intakes through whole foods, not supplements.
Higher plant-to-animal protein ratios are observationally linked to lower CVD/CAD risk but not direct protocol efficacy.
Large cohorts provide source-pattern mortality context, not causal protein-floor evidence.
EPIC-CVD preserves a null overall source association with selected observational substitution signals.
Food-first review supports source/matrix awareness but is not trial evidence.
Protein-increase advice can change sustainability metrics through source mix.
Older-adult perceptions support food-first implementation planning, not efficacy claims.
Training and athlete sources are important adjacent support for protein and lean-mass interpretation, but they are not direct proof of a food-based daily floor without a training cointervention.
40 sources · 21 trials · 16 reviews · 1 physiology study
Athlete narrative review is guidance context.
Protein timing meta-analysis is implementation context.
Arctic military field study is stress-context mechanism evidence.
Per-meal protein review informs implementation, not efficacy.
Track-and-field protein review is sport-specific context.
Older-adult metabolic/signaling RCT is mechanistic context.
Athlete intake-strata study is noncausal context.
Acute MPS dose-response is mechanism, not daily floor efficacy.
Male weight-loss RCT is adjacent physical-performance context.
Protein distribution evidence is mixed and not daily-dose proof.
Proteomic RCT is mechanistic context, not protocol efficacy.
Frail-elderly protein trial belongs to clinical/frailty context.
Lean-athlete caloric-restriction review defines a higher-dose variant boundary.
Recovery-focused high-versus-moderate protein trial is adjacent.
Habitual-intake strata in older women are context, not randomized floor proof.
Post-hospital protein-enriched foods improved intake but not performance.
Older-adult protein-plus-resistance-exercise synthesis informs subgroup context.
Female physique-athlete RCT informs specialized body-composition variants.
Frail/undernourished elderly RCT is clinically important but population-mismatched.
Physically active older-adult RCT supports lean-mass context.
Protein-matched vegan/omnivore trial informs source delivery.
Whole-food high-protein diet plus concurrent training informs older-adult implementation.
Senior habitual-protein RCT informs implementation boundaries.
Recent active-adult RCT is close but short and context-dependent.
Energy-restricted trained-athlete meta-regression is adjacent, not direct floor evidence.
Small novice-bodybuilder study supports adequacy boundaries, not unlimited dose escalation.
Energy-restricted high-protein diet meta-analysis is weight-loss context.
Protein supplementation plus resistance training supports muscle-adaptation context.
Very-high-protein trained-user trial is an upper-bound comparator.
Older-adult weight-loss factorial trial is useful but cointervention-limited.
Postmenopausal resistance-exercise RCT did not show added lean-mass gain.
Nonfrail older-adult meta-analysis is mixed, not universally supportive.
Elderly protein-plus-resistance-training synthesis supports mass/strength but function is mixed.
Recent recreational-athlete dieting RCT is adjacent and needs detailed extraction before claims.
Higher protein reduced lean-mass loss in short athlete cuts.
Higher protein improved body-composition outcomes in intense exercise plus energy deficit.
Modern healthy-adult synthesis supports muscle-outcome context.
Protein-plus-strength-training dose-response supports strength context.
Resistance-training meta-regression anchors the 1.6 g/kg/day neighborhood.
Broad dose-response meta-analysis supports muscle-mass boundary framing.
Additional athlete, recovery, and training-context sources help prevent overclaiming strength, soreness, or performance improvements from protein alone.
8 sources · 4 trials · 4 reviews
Target-range protein with supervised resistance training improved body composition and performance in overweight women.
Protein supplementation improved lean body mass, but timing and strength outcomes were not clearly confirmed.
Protein supplementation did not add clear strength or performance gains on top of resistance training in healthy older adults.
In vegetarians, 2.0 g/kg/day did not outperform 1.2 g/kg/day for short-term EIMD recovery.
Very high protein did not improve short-term muscle-damage recovery versus moderate protein.
Breakfast protein may help with muscle-mass signals, but strength and causal evidence are unclear.
Protein-distribution commentary supports flexibility, not a direct outcome claim.
Low-dose whey did not preserve lean mass more than sucrose during extreme energy deficit.
Population, sex, age, baseline-intake, denominator, and requirement-method sources show why user context must be logged before interpreting response.
40 sources · 19 trials · 17 supporting sources · 3 reviews
Higher-protein ad libitum low-fat diet improved weight and fat loss in adults with obesity.
Higher protein reduced lean-mass loss during weight loss in postmenopausal women.
Protein-for-carbohydrate substitution changed lipid markers in a short-term hypercholesterolemia setting.
Higher protein affected regional body composition but not total composition in overweight/obese adults.
A 1.7 g/kg/day high-protein diet did not preserve lean mass during older-adult energy restriction.
Higher-protein weight-loss diets in older adults favored lean-mass retention and fat loss in synthesis.
Adherence depends on habit fit, knowledge, taste, convenience, and packaging.
Higher protein improved appendicular lean-mass/function signals in elderly men.
Protein above the RDA did not improve lean mass or function in functionally limited older men.
Higher-protein adherence was linked with more favorable body-composition changes in older women exercising.
Higher-protein energy-restricted meal plan reduced body mass/fat mass in older adults with obesity.
Two advice strategies raised older adults’ protein intake over four weeks.
Euenergetic high-protein diet did not cause significant weight loss in women with normal-weight obesity.
Personalized advice to reach ≥1.2 g/kg aBW/day improved physical-function signals and cost-effectiveness in older low-intake adults.
Health Council review found insufficiently convincing benefit for raising protein above 0.8 g/kg/day in already-adequate older adults.
Higher protein at 1.2 g/kg did not improve satiety or weight loss over normal protein in an 8-week low-energy diet.
PROMISS secondary analysis supports feasibility of personalized protein-increase advice in older low-intake adults.
Protein-rich meals and snacks can raise older adults’ protein intake cost-effectively.
Older consumers varied in acceptance of protein-enriched food carriers.
Higher-protein macronutrient substitution improved glycemic response in type 2 diabetes.
High-protein diet mechanisms are plausible, but early weight-loss evidence was inconsistent and short term.
Higher habitual protein intake was associated with less lean-mass loss in older adults.
Higher protein during energy restriction supported muscle retention/physical function in older women.
IAAO estimated protein requirement in octogenarian women above classic EAR values but below the Murph floor.
Protein-enriched regular foods increased intake in hospitalized older adults.
IAAO estimated older women’s protein requirement above conventional RDA assumptions.
IAAO estimated older men’s protein requirement/RDA above current EAR assumptions.
Protein-enriched familiar foods may help institutionalized older adults increase intake.
Protein-enriched familiar foods improved protein intake in hospitalized older patients.
Whole-egg high-protein diet supported lean retention but not broader cardiometabolic or inflammation improvements.
IAAO postexercise estimates in trained females fall within/near the Murph target range.
Postexercise whole-body anabolism in trained men plateaued near 2.0 g/kg/day.
IAAO estimated Chinese older-adult protein requirements modestly above current estimates.
Protocol proposes high-protein diet with/without power training in pre-frail/frail adults.
Protein above RDA lowered visceral fat but did not improve cardiometabolic risk markers.
PROMISS protocol defines personalized advice to reach ≥1.2 g/kg adjusted body weight/day.
Low protein-awareness may limit uptake of higher-protein advice in older adults.
Additional protein at a 1.5 g/kg normalized-body-weight target did not preserve body composition during formula-based obesity treatment.
Adding 20 g/day protein did not improve older-adult muscle-function outcomes over 12 weeks.
IAAO in sarcopenic older adults estimated an RNI around 1.54 g/kg/day.
Metabolic labs are endpoint-specific and source-quality-sensitive; favorable triglyceride, HDL, glucose, insulin, or HbA1c signals coexist with null, LDL, TMAO, and observational cautions.
27 sources · 20 trials · 4 reviews · 3 supporting sources
Named-diet trial cannot isolate protein from low-carbohydrate diet pattern.
LoBAG diet improved glucose in a very small untreated T2D crossover trial.
Protein overfeeding study is mechanistic context, not protocol efficacy evidence.
Small T2D crossover study reported improved glucose control with 30% protein/40% carbohydrate.
Moderate higher-protein diets did not differentially improve most cardiometabolic markers.
Glutamate-rich high-protein feeding produced adverse lipid-mechanism signals in a small mechanistic study.
Carbohydrate-to-protein substitution lowered lipids in a controlled setting, but dose details are incomplete.
High-protein diet plus exercise improved weight and some lipids, but attribution is confounded.
Assigned high protein did not outperform high carbohydrate, but reported protein intake correlated with weight loss.
T2D 12-month trial found no superior metabolic benefit for high-protein advice.
Near-target high protein preserved lean mass but did not improve cardiometabolic markers beyond normal protein.
High-protein low-fat diet did not outperform higher-carbohydrate low-fat diet in T2D.
High-protein diet improved several cardiometabolic and inflammatory markers in women with obesity.
Short inpatient high-protein feeding improved insulin resistance and glycemic variability.
Recent network meta-analysis favored higher-protein diet nodes for body-composition outcomes.
High-protein/lower-carbohydrate advice produced mixed long-term cardiometabolic signals in obese adults with T2D.
A small T2D trial found blood-pressure benefit but no clear glycemic advantage for high protein.
High protein modestly outperformed a higher-fiber diet for weight, fat, and diastolic blood pressure over 8 weeks.
T2D meta-analysis favored high protein for short-term weight and HbA1c but not lipids or fasting glucose.
Carbohydrate-reduced high-protein feeding improved glycemic and hepatic-fat markers in T2D.
Large 3-year prevention trial found no high-protein/low-GI advantage for T2D incidence.
A 1.6 g/kg/day higher-protein weight-loss diet improved glucose/insulin dynamics without greater weight loss.
Long-term high-protein/lower-carbohydrate assignment did not outperform standard protein for weight or lab changes.
Large maintenance trial did not identify high protein as the clear cardiometabolic benefit driver.
Long-term RCT meta-analysis found only a small fasting-insulin advantage and little else.
Controlled feeding found no broad high-protein advantage for insulin sensitivity or lipids.
Large RCT meta-analysis found small favorable effects on selected cardiometabolic markers.
Healthy-adult renal-marker findings are not CKD clearance. This group supports kidney-context screening, optional labs, and clinician-guided decisions for abnormal renal status.
34 sources · 13 trials · 13 reviews · 5 observational studies
Older athlete study found no measured renal impairment below ~2.8 g/kg/day.
Older-adult protein-advice trial is implementation context, not renal evidence.
Nursing-home ONS trial found no renal deterioration over eight weeks.
Very-low-carbohydrate weight-loss trial is adjacent renal-safety context.
T2D high-protein weight-loss trial found no overall renal-function change.
Older-adult cohort found no major kidney-decline impact from higher protein.
One-year T2D low-carb high-protein trial found no adverse renal-marker effect.
Small trained-male crossover found no deleterious markers at >3 g/kg/day.
Low-carbohydrate renal meta-analysis is adjacent, not direct protein-floor evidence.
Small trained-male crossover found no renal/liver/lipid harm at very high protein.
Plant-versus-animal protein review informs source quality, not renal claims.
T2D source-comparison trial is adjacent source-quality evidence.
Tehran cohort suggests plant-protein source context for CKD risk.
T2D high- versus normal-protein trial is adjacent clinical context.
Protein-supplement review supports supplement-specific renal caution.
Prospective-cohort meta-analysis reports lower CKD risk associations, not causal protection.
Narrative renal-safety review separates healthy populations from susceptible groups.
Cohort evidence differs by baseline renal function.
Protein-kidney review supports healthy-vs-CKD separation.
Short-term 2.4 g/kg/day study shows renal hemodynamic response.
Broad meta-analysis shows mixed safety/tolerability signals rather than a clean renal claim.
Controlled feeding protein-rich diet increased eGFR without resolving long-term kidney risk.
Healthy-adult systematic review is useful context, not a target-dose renal trial.
High-protein diets changed renal workload markers in non-CKD adults.
Adverse-effect review identifies safety domains for above-RDA protein intake.
Long-term renal review emphasizes uncertainty and protein-source boundaries.
Healthy-adult meta-analysis does not show adverse GFR change from higher protein.
Cohort links high-protein plus hyperfiltration to rapid renal decline.
Nephrology review preserves a conservative renal-risk mechanism.
KDOQI guideline makes CKD a medical-nutrition boundary.
ESPEN guideline defines hospitalized kidney disease as clinician-supervised.
1.6 g/kg/day trial measured kidney markers and found creatinine changes.
Training trial overlaps 1.6 g/kg/day and includes 3.2 g/kg/day high-dose boundary.
KDIGO guideline anchors CKD screening and management boundaries.
Stone and gout sources are source- and urine-chemistry-specific. They support screening and clinician-directed source rules rather than a source-agnostic protein increase.
21 sources · 6 trials · 5 observational studies · 5 reviews
Six-month soy interventions did not increase serum urate in a narrow postmenopausal-women population.
EULAR gout guidance is management context, not protein-floor efficacy evidence.
Low-animal-protein/high-fiber advice showed no advantage over fluids alone for recurrent calcium oxalate stones.
Short wheat-gluten high-protein feeding lowered serum urate, but it is source-specific context.
Animal-protein stone risk was observed only in leaner men in a long prospective cohort.
NHANES III links meat and seafood to higher serum urate and dairy to lower serum urate.
Low-animal-protein advice did not reduce calcium-stone recurrence in this trial.
Dietary calcium was protective context, while animal protein had a modest observational stone signal.
Gout risk in men was source-specific: meat/seafood higher, dairy lower, total protein not the same signal.
Two-year low-carb high-protein dieting did not show clear renal-marker harm, but urinary calcium rose.
Incident gout risk differed by protein source in a large Singapore Chinese cohort.
A DASH-style higher-protein feeding pattern modestly reduced serum urate.
Recurrent hypercalciuric stone formers benefited from a normal-calcium, low-animal-protein, low-salt diet.
Added animal protein raised urinary calcium in a controlled metabolic setting.
Short-term healthy-adult renal markers were generally reassuring, but stone and long-term certainty were limited.
Observational evidence separates nondairy animal protein from dairy protein for stone risk.
Umbrella review did not find proof that higher protein triggers stones or kidney disease, but long-term evidence is limited.
EAU stone guidance sets a lower animal-protein and purine boundary for stone-prone users.
NICE does not support claiming any specific diet as proven gout treatment.
AUA kidney-stone guidance requires protein-source limits in selected stone phenotypes.
ACR gout guidance makes serum-urate control and comorbidity status primary safety constraints.
This group preserves GI tolerance, fiber displacement, microbiome, pregnancy, and liver-disease safety boundaries, including mixed and negative pregnancy-supplementation signals.
12 sources · 4 trials · 3 guidance sources · 2 reviews
High-protein calorie restriction altered microbiome composition without clear weight-loss superiority.
Raising older adults to 1.2 g/kg adjusted body weight did not disturb microbiota or appetite.
Target-range high protein was short-term tolerable in older women but shifted microbiota taxa.
Large Nordic cohorts show mixed pregnancy context: no fetal-growth/mortality harm but modest preterm signal.
About 1.6 g/kg/day did not add strength benefit but showed no short-term renal/glycemic/cardiovascular biomarker harm.
High-protein low-carbohydrate/fiber diets worsened colonic-health metabolite profiles.
EASL supports adequate protein in cirrhosis under clinical supervision, not blanket restriction.
ESPEN frames liver-disease protein intake as individualized clinical nutrition.
Food-based 1.6 g/kg/day in older adults showed no adverse GI microbiota composition signal over 17 weeks.
Older Cochrane pregnancy review flags high-protein supplementation as no-benefit and potentially harmful.
Updated Cochrane review finds high-protein pregnancy supplementation increased SGA risk in one trial.
WHO does not recommend high-protein supplementation in undernourished pregnancy.
Short-term selected-population safety marker data can be reassuring in narrow contexts but do not establish lifetime safety or justify escalating beyond the floor.
10 sources · 8 trials · 1 observational study · 1 review
Extreme 4.4 g/kg/day protein did not improve body composition in young resistance-trained adults.
High protein did not preserve testosterone or IGF-I during short-term energy deficit.
A 24-month calcium-replete higher-protein weight-loss diet did not worsen BMD in postmenopausal women.
Short-term 1.6-2.4 g/kg/day protein did not disrupt calcium homeostasis in healthy young adults.
Higher protein during weight loss preserved modest lean mass but blunted insulin-action improvement in postmenopausal obesity.
Twice-RDA protein in older men increased TMAO and LDL, without differences in other CVD biomarkers or insulin sensitivity.
Controlled 1.6 g/kg/day protein in older men produced limited metabolomic changes.
High protein plus strength training showed no major oxidative-stress signal in older adults.
UK Biobank high-protein intake ≥1.8 g/kg/day was associated with higher CVD risk, especially after age 55.
Older adults achieved about 1.6 g/kg/day with modest metabolomic shifts and no renal/liver disruption signal.
Adherence, appetite, cost, meal planning, GI comfort, and support needs should be measured because assigned diet and achieved intake often diverge.
11 sources · 6 trials · 5 supporting sources
DIOGENES participants rated higher-protein maintenance diets as more acceptable than low-protein diets.
Higher-protein DIOGENES diets reduced 12-month weight regain under a supported free-living model.
PREVIEW found lower hunger with high-protein/low-GI maintenance but no clear weight-regain advantage.
Higher percent-energy protein reduced appetite and ad libitum intake in a small controlled study.
Pro-HEART improved cardiometabolic markers more with high protein, but weight loss was similar and clinical support was intensive.
Higher-protein diet improved short-term weight loss but long-term durability was uncertain.
A 1.6 g/kg/day higher-protein diet plus exercise context improved body-composition signals in adult women.
POUNDS Lost protein-intake markers were associated with greater weight-loss success.
Fiber intake predicted weight loss and adherence in POUNDS Lost, providing diet-quality context for protein-floor design.
A small heart-failure feasibility study reported favorable short-term clinical and quality-of-life signals.
A meal-kit CRHP protocol provides implementation design but no results yet.
External protocols and guidelines provide context for source quality, protein requirements, disease boundaries, and public implementation, but are not Murph protocol claims.
15 sources · 12 guidance sources · 3 reviews
National Academies DRI provides the RDA comparator and AMDR context, not a protein-floor efficacy claim.
Older-adult systematic review shows lean-mass and strength-with-exercise signals, plus important null and uncertain endpoints.
PROT-AGE supports higher protein targets in older adults, with kidney-disease boundaries.
ESPEN links higher protein and exercise for older-adult muscle-function preservation.
Sports-nutrition position statement places active users near the protein-floor range.
ISSN 2017 gives the clearest sports-guideline overlap with the 1.5-2.0 g/kg/day protocol band.
AHRQ review finds protein-health evidence unclear for bone, kidney, and sarcopenia outcomes.
Current U.S. Dietary Guidelines list 1.2-1.6 g/kg/day protein serving goals but are external guidance, not efficacy evidence.
AHA 2001 cautions against overinterpreting early high-protein weight loss and poor diet-quality substitutions.
ISSN 2007 is historical support for the sports-nutrition 1.4-2.0 g/kg/day range.
Obesity guideline contextualizes weight outcomes but does not test protein-floor dosing.
MSSE cross-publication supports athlete-context guidance but should not be double-counted.
ISSN nutrient timing adds meal-distribution context to the daily protein floor.
My New Gut position paper flags gut-health and fiber-displacement boundaries for high-protein weight-management diets.
AHA 2021 keeps protein-floor implementation inside a cardiovascular dietary-pattern frame.
Trial registries identify planned or ongoing evidence seams and should not be treated as outcome evidence.
9 sources · 8 supporting sources · 1 trial
Named-diet registry context, not a protein-dose trial
DiOGenes registry is publication-linkage and design context
Adjacent high-dose protein plus intense-training registry context
Lower-dose high-protein meal-replacement registry context
Older-adult higher-protein weight-loss registry results are adjacent and mixed
Acute metabolic-chamber context for high-protein total diet replacement
Acute men's metabolic-chamber context for high-protein total diet replacement
Supervised older-adult 1.5 g/kg/day registry design without posted results
Registry context for protein distribution physiology, not daily protein-floor efficacy
Miscellaneous context records remain separated from direct protocol evidence.
1 source · 1 trial
Post-sleeve 2.0 g/kg ideal-body-weight protein favored fat-mass, FFM, and RMR outcomes in a male bariatric population.